¼¼°èÀÇ ÀǾàǰ µî±Þ ¼¿·ê·Î¿À½º ºÐ¸» ½ÃÀå º¸°í¼­(2025³â)
Pharma Grade Cellulose Powder Global Market Report 2025
»óǰÄÚµå : 1760687
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,233,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,010,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,786,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÀǾàǰ µî±Þ ¼¿·ê·Î¿À½º ºÐ¸» ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö 6.2%ÀÇ CAGR·Î 16¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ¿¹»óµÇ´Â ¼ºÀåÀº ¸ÂÃãÇü ÀÇ·áÀÇ ºÎ»ó, Áö¼Ó°¡´ÉÇÑ ºÎÇüÁ¦·ÎÀÇ Àüȯ, »ý¹°ÇÐÀû Á¦Á¦ ¹× ¹ÙÀÌ¿À½Ã¹Ð·¯ÀÇ È®´ë, °æ±¸ ¾à¹°Àü´Þ ±â¼ú Çõ½Å¿¡ ´ëÇÑ °ü½É Áõ°¡, ½ÅÈï ½ÃÀåÀÇ Á¦¾à ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ È®´ë µîÀÇ ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ÀǾàǰ ºÎÇüÁ¦ µî±Þ Àç·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¹æÃâ Á¦¾î ¾à¹°Àü´Þ ½Ã½ºÅÛ »ç¿ë Áõ°¡, ½Ä¹° À¯·¡ ¹× Àç»ý °¡´ÉÇÑ ºÎÇüÁ¦·ÎÀÇ Àüȯ, Á¦¾î ¾à¹°Àü´Þ ½Ã½ºÅÛ Ã¤Åà Áõ°¡, ¼øµµ ¹× ¼º´É Çâ»óÀ» À§ÇÑ ¼¿·ê·Î¿À½º °¡°ø ±â¼ú ¹ßÀü µîÀÌ ÀÖ½À´Ï´Ù. ¼¿·ê·Î¿À½º °¡°ø ±â¼úÀÇ ¹ßÀü µîÀ» µé ¼ö ÀÖ½À´Ï´Ù.

ÇコÄɾ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÀǾàǰ Á¦Á¶°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÔ¿¡ µû¶ó ÀǾàǰ µî±Þ ¼¿·ê·Î¿À½º ºÐ¸» ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀǾàǰ Á¦Á¶¿¡´Â ¾ÈÀü¼º, À¯È¿¼º, ±ÔÁ¦ Áؼö¸¦ º¸ÀåÇϱâ À§ÇÑ À¯È¿ ¼ººÐ ¹× ºÎÇüÁ¦ÀÇ ¹èÇÕ, ÇÕ¼º, ǰÁú °ü¸®°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ ºÎ¹®Àº Àå±â Åõ¾àÀÌ ÇÊ¿äÇÑ ¸¸¼ºÁúȯÀÇ È®»êÀ¸·Î ÀÎÇØ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀǾàǰ µî±Þ ¼¿·ê·Î¿À½º ºÐ¸»Àº ½Å·ÚÇÒ ¼ö ÀÖ´Â °áÇÕÁ¦, ÃæÁøÁ¦, ¾ÈÁ¤Á¦ ¿ªÇÒÀ» Çϸç, Á¤Á¦ÀÇ ¹«°á¼º°ú ¾ÈÁ¤ÀûÀÎ ÀǾàǰ À¯ÅëÀ» º¸ÀåÇÏ¿© ÀǾàǰ Á¦Á¶¸¦ Áö¿øÇÏ´Â Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 6¿ù À¯·´Á¦¾àÇùȸ(EFPIA)´Â À¯·´ÀÇ ÀǾàǰ »ý»ê ÃѾ×ÀÌ 4,228¾ï 300¸¸ ´Þ·¯(3,900¾ï À¯·Î)·Î 2022³â 3,938¾ï 5,700¸¸ ´Þ·¯(3,633¾ï À¯·Î)¿¡¼­ Áõ°¡Çß´Ù°í º¸°íÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ÀǾàǰ »ý»êÀÇ ¼ºÀåÀÌ ÀǾàǰ µî±Þ ¼¿·ê·Î¿À½º ºÐ¸» ½ÃÀåÀÇ È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ÀǾàǰ µî±Þ ¼¿·ê·Î¿À½º ºÐ¸» ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº ¹Ì°áÁ¤ ¼¿·ê·Î¿À½º(MCC) »ý»ê ½Ã¼³ÀÇ È®Àå¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àü¿ë ½Ã¼³¿¡¼­´Â Á¤Á¦µÈ ¼¿·ê·Î¿À½º¸¦ Á¦¾îµÈ È­ÇÐÀû ¹× ±â°èÀû 󸮸¦ ÅëÇØ °¡°øÇÏ¿© ÀǾàǰ¿ë ¹Ì¼¼ ÀÔÀÚ¸¦ »ý»êÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, Àεµ¿¡ º»»ç¸¦ µÐ ºÎÇüÁ¦ Á¦Á¶¾÷üÀÎ Nichika Pharmaceuticals Specialties´Â 2023³â 9¿ù Àεµ ÃÖ´ë ±Ô¸ðÀÇ ¹Ì°áÁ¤ ¼¿·ê·Î¿À½º(MCC) »ý»ê °øÀåÀ» ³ª±×Ǫ¸£¿¡ ¼³¸³Çß½À´Ï´Ù. 1,200ÅæÀÇ »ý»ê´É·ÂÀ» °®Ãá ÀÌ ÃÖ½Å½Ä ½Ã¼³Àº ´Ïƾ °¡µåÄ®¸®(Nitin Gadkari) ¿¬¹æ Àå°üÀÌ Áذø½ÄÀ» °¡Á³À¸¸ç, Àεµ Á¤ºÎÀÇ ºÎÇüÁ¦¿¡ ´ëÇÑ »ý»ê ¿¬µ¿Çü Àμ¾Æ¼ºê(PLI) Á¦µµÀÇ Áß¿äÇÑ ¼º°ú·Î Æò°¡¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ °øÀåÀº ´ÏġīÁ¦¾àÀÇ ÀǾàǰ ºÎÇüÁ¦ÀÇ ¼¼°è ¸®´õ·Î¼­ÀÇ ¿ªÇÒÀ» °­È­ÇÏ¿© ±¹³» ¼ö¿ä¿Í 92°³±¹ ÀÌ»ó¿¡ ´ëÇÑ ¼öÃâÀ» Áö¿øÇÏ´Â µ¿½Ã¿¡ '¸ÞÀÌÅ© ÀÎ Àεð¾Æ' ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÃËÁøÇϰí ÇöÁö¿¡ ¸¹Àº °í¿ë ±âȸ¸¦ âÃâÇÒ °ÍÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ª ÀüÀï°ú °ü¼¼, Äڷγª¿Í ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Pharma-grade cellulose powder is a highly refined, plant-derived substance engineered to adhere to rigorous pharmaceutical quality criteria. It is frequently utilized as an excipient in drug formulations. Its properties of chemical inertness, non-toxicity, and stability ensure it is compatible with active pharmaceutical ingredients (APIs). Additionally, it improves the consistency and manufacturing efficiency of oral solid dosage forms.

The primary types of pharma-grade cellulose powder include microcrystalline cellulose (MCC), carboxymethyl cellulose (CMC), hydroxypropyl methylcellulose (HPMC), and hydroxypropyl cellulose (HPC). Microcrystalline cellulose (MCC) is a stable, compressible derivative of wood pulp that is widely used in the pharmaceutical industry as a binder, filler, and disintegrant due to its superior flow and direct compression characteristics. It serves multiple functions such as a binder, thickener, stabilizer, disintegrant, and coating agent, applicable in pharmaceuticals, nutraceuticals, cosmetics, and more. It is utilized by a variety of users, including contract research organizations (CROs), pharmaceutical and biotechnology firms, academic institutions, dietary supplement manufacturers, and the food and beverage sector.

The pharma grade cellulose powder market research report is one of a series of new reports from The Business Research Company that provides pharma grade cellulose powder market statistics, including the pharma grade cellulose powder industry global market size, regional shares, competitors with the pharma grade cellulose powder market share, detailed pharma grade cellulose powder market segments, market trends, opportunities, and any further data you may need to thrive in the pharma grade cellulose powder industry. This pharma grade cellulose powder market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharma-grade cellulose powder market size has grown strongly in recent years. It will grow from $1.19 billion in 2024 to $1.27 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth observed in the historical period can be attributed to factors such as the rising demand for tablet binders, increased production of generic drugs, greater investment in pharmaceutical research and development, expansion in excipient manufacturing capacity, and regulatory approvals for cellulose-based excipients.

The pharma-grade cellulose powder market size is expected to see strong growth in the next few years. It will grow to $1.62 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The anticipated growth during the forecast period is driven by factors such as the rise of personalized medicine, the shift toward sustainable excipients, the expansion of biologics and biosimilars, an increasing focus on innovations in oral drug delivery, and growing investments in pharmaceutical infrastructure in emerging markets. Key trends in the forecast period include a growing demand for excipient-grade materials in drug formulations, the increasing use of controlled-release drug delivery systems, a shift towards plant-based and renewable excipients, a rise in controlled drug delivery system adoption, and advancements in cellulose processing technologies to enhance purity and performance.

The increasing demand for healthcare is expected to drive the growth of the pharma-grade cellulose powder market, as pharmaceutical production continues to rise. Pharmaceutical manufacturing involves the formulation, synthesis, and quality control of active ingredients and excipients to ensure safety, effectiveness, and regulatory compliance. This sector is expanding due to the growing prevalence of chronic diseases that require long-term medication. Pharma-grade cellulose powder plays a crucial role in supporting pharmaceutical production by serving as a reliable binder, filler, and stabilizer, ensuring tablet integrity and consistent drug distribution. For example, in June 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA) reported that total pharmaceutical production in Europe reached $422,803 million (€390,000 million), an increase from $393,857 million (€363,300 million) in 2022. This growth in pharmaceutical production is contributing to the expansion of the pharma-grade cellulose powder market.

Leading companies in the pharma-grade cellulose powder market are focusing on expanding microcrystalline cellulose (MCC) production facilities. These dedicated facilities process purified cellulose through controlled chemical and mechanical treatments to create fine-grade particles for pharmaceutical use. For instance, in September 2023, Nitika Pharmaceuticals Specialties, an India-based excipient manufacturer, opened India's largest microcrystalline cellulose (MCC) manufacturing plant in Nagpur. This state-of-the-art facility, with an installed capacity of 1,200 metric tons, was inaugurated by Union Minister Nitin Gadkari and marks a key achievement under the Indian Government's Production Linked Incentive (PLI) scheme for excipients. This plant enhances Nitika Pharma's role as a global leader in pharmaceutical excipients, supporting both domestic demand and exports to over 92 countries, while also advancing the "Make in India" initiative and creating significant local employment opportunities.

In December 2024, Nordic Bioproducts Group, a Finland-based manufacturer of microcrystalline cellulose (MCC), formed a partnership with C.Q. Masso to enhance the supply of sustainable MCC for the beauty and personal care industries. This collaboration seeks to help manufacturers meet evolving EU regulations on harmful ingredients and product traceability by providing MCC as a renewable, wood-derived alternative to substances such as talc and titanium dioxide. The partnership supports the industry's move toward safer, more environmentally friendly formulations while ensuring a reliable and traceable supply chain across Europe. C.Q. Masso, based in Spain, specializes in manufacturing chemical products for various industries.

Major players in the pharma grade cellulose powder market are Roquette Freres, Ashland Global, JRS Pharma, Ankit Pulps & Boards Pvt. Ltd., DFE Pharma, Sigachi Industries Ltd., Accent Microcell Ltd., Maple Biotech Pvt. Ltd., Mingtai Chemical Co. Ltd., Patel Chem Specialties Limited, CelluTech, RanQ, Aromatic Cellulose Pvt. Ltd., Maruti Chemicals, Weifang Lude Chemical Co., Ltd., Patco Pharmaceuticals Pvt. Ltd., RK Dyechem Private Limited, Chemfield Cellulose, Vizag chemical, Tirumala inorganics

North America was the largest region in the pharma-grade cellulose powder market in 2024. The regions covered in pharma-grade cellulose powder report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharma-grade cellulose powder market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharma-grade cellulose powder market consists of sales of sodium carboxymethyl cellulose and cellulose acetate phthalate. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharma Grade Cellulose Powder Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharma grade cellulose powder market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for pharma grade cellulose powder ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharma grade cellulose powder market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Pharma Grade Cellulose Powder Market Characteristics

3. Pharma Grade Cellulose Powder Market Trends And Strategies

4. Pharma Grade Cellulose Powder Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pharma Grade Cellulose Powder Growth Analysis And Strategic Analysis Framework

6. Pharma Grade Cellulose Powder Market Segmentation

7. Pharma Grade Cellulose Powder Market Regional And Country Analysis

8. Asia-Pacific Pharma Grade Cellulose Powder Market

9. China Pharma Grade Cellulose Powder Market

10. India Pharma Grade Cellulose Powder Market

11. Japan Pharma Grade Cellulose Powder Market

12. Australia Pharma Grade Cellulose Powder Market

13. Indonesia Pharma Grade Cellulose Powder Market

14. South Korea Pharma Grade Cellulose Powder Market

15. Western Europe Pharma Grade Cellulose Powder Market

16. UK Pharma Grade Cellulose Powder Market

17. Germany Pharma Grade Cellulose Powder Market

18. France Pharma Grade Cellulose Powder Market

19. Italy Pharma Grade Cellulose Powder Market

20. Spain Pharma Grade Cellulose Powder Market

21. Eastern Europe Pharma Grade Cellulose Powder Market

22. Russia Pharma Grade Cellulose Powder Market

23. North America Pharma Grade Cellulose Powder Market

24. USA Pharma Grade Cellulose Powder Market

25. Canada Pharma Grade Cellulose Powder Market

26. South America Pharma Grade Cellulose Powder Market

27. Brazil Pharma Grade Cellulose Powder Market

28. Middle East Pharma Grade Cellulose Powder Market

29. Africa Pharma Grade Cellulose Powder Market

30. Pharma Grade Cellulose Powder Market Competitive Landscape And Company Profiles

31. Pharma Grade Cellulose Powder Market Other Major And Innovative Companies

32. Global Pharma Grade Cellulose Powder Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharma Grade Cellulose Powder Market

34. Recent Developments In The Pharma Grade Cellulose Powder Market

35. Pharma Grade Cellulose Powder Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â